Carcinoma, Squamous Cell: all 1,779 studies
Page 14 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)CompletedNCT02836522
- Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN LossTerminatedNCT02822482Phase 1/2
- Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the PenisActive, not recruitingNCT02817958Phase 2
- Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCCStatus unknownNCT02812641Phase 2
- Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT02778191
- Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and NeckCompletedNCT02776137Phase 2
- Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell CarcinomaCompletedNCT02775812Phase 1
- Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO TrialStatus unknownNCT02765503Not applicable
- Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck CancerCompletedNCT02764593Phase 1
- Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant ChemotherapyStatus unknownNCT02753140Phase 2
- TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility StudyCompletedNCT02752932Not applicable
- Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized StudyStatus unknownNCT02748707Phase 2
- Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell CarcinomaStatus unknownNCT02739204Phase 2
- Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their PrecursorsTerminatedNCT02735109Not applicable
- Investigation of Desmoplastic Squamous Cell CarcinomaStatus unknownNCT02717936Not applicable
- Changes in Body Composition After EPA Supplementation in Head and Neck PatientsCompletedNCT02715596Phase 3
- Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCCCompletedNCT02707588Phase 2
- Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCCWithdrawnNCT02686008Phase 1
- Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT02677597Phase 3
- New Strategies Against Cutaneous Squamous Cell CarcinomaCompletedNCT02672254
- Optical Imaging for Preoperative Delineation of Nonmelanoma Skin CancersStatus unknownNCT02666833
- Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell CarcinomaCompletedNCT02666534Phase 1
- Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasStatus unknownNCT02665702Phase 2
- National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerCompletedNCT02664935Phase 2
- Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous CellStatus unknownNCT02663583
- DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.Status unknownNCT02661152Phase 3
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck CancerTerminatedNCT02655068Phase 3
- A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell CarcinomaWithdrawnNCT02649530Phase 2
- Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)CompletedNCT02649361Phase 2
- A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCCCompletedNCT02647125Phase 2
- Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell CarcinomaCompletedNCT02645864Phase 1
- Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With ChemoradiotherapyCompletedNCT02644408Phase 3
- Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02643550Phase 1/2
- Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCCStatus unknownNCT02639858Phase 2
- A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Status unknownNCT02637531Phase 1
- E10A for the Treatment of Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT02630264Phase 3
- Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac CancerStatus unknownNCT02628665Phase 3
- Outcomes of FoundationOne Directed Therapy in Cancer of Unknown PrimaryCompletedNCT02628379
- Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & NeckWithdrawnNCT02624999Phase 2
- Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT02611700Phase 3
- Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic AcidCompletedNCT02608736Early Phase 1
- Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous CancerStatus unknownNCT02607540Phase 3
- Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.CompletedNCT02606916Phase 2
- Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent ChemoradiotherapyStatus unknownNCT02603159Phase 3
- Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck CancerWithdrawnNCT02593929Early Phase 1
- Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of EsophagusStatus unknownNCT02586753Phase 2
- Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCCCompletedNCT02585973Phase 1
- Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyTerminatedNCT02582008Early Phase 1
- Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSILStatus unknownNCT02576561Phase 2
- GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer PatientsCompletedNCT02575404Phase 1
- A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT02570893Phase 3
- ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsCompletedNCT02565758Phase 1
- Swallowing, Speech and Quality of Life of Patients With Carcinoma of the OropharynxTerminatedNCT02552550
- Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to RadiochemotherapyTerminatedNCT02551458Phase 2/3
- Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaTerminatedNCT02549638
- PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCCCompletedNCT02544880Phase 1
- SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)CompletedNCT02543476
- AMG 319 in HPV Positive and Negative HNSCCTerminatedNCT02540928Phase 2
- Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck CancerCompletedNCT02537223Phase 1
- Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma PatientsStatus unknownNCT02526953Phase 3
- Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous CarcinomaStatus unknownNCT02513342Phase 4
- WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and NeckCompletedNCT02508246Phase 1
- Reactivating NK Cells in Treating Refractory Head and Neck CancerStatus unknownNCT02507154Phase 1/2
- Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' PatientsStatus unknownNCT02495064Phase 4
- Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell CancerStatus unknownNCT02485548Phase 3
- A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the CervixStatus unknownNCT02482740Phase 2
- A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02479178Phase 2
- Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)Active, not recruitingNCT02465736Phase 3
- Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT02461043Phase 3
- A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal CancerCompletedNCT02459457Phase 3
- Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or SkinTerminatedNCT02449681Phase 2
- Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell CarcinomaCompletedNCT02446574Phase 1/2
- Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation ToxicityCompletedNCT02442375Phase 3
- Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02438995Phase 1
- Safety Study of AMG 228 to Treat Solid TumorsTerminatedNCT02437916Phase 1
- The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck CancersCompletedNCT02435602Not applicable
- Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and NeckTerminatedNCT02429089Phase 1
- Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent ChemoradiotherapyCompletedNCT02423811Phase 2
- Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal CancerCompletedNCT02415101Not applicable
- EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision WoundsCompletedNCT02409628Not applicable
- A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell CarcinomaStatus unknownNCT02409186Phase 3
- Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal CarcinomaCompletedNCT02399306Phase 3
- Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell CarcinomaCompletedNCT02395705Phase 3
- Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell CarcinomaStatus unknownNCT02384811Phase 2
- Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and CisplatinCompletedNCT02381535Phase 1
- Multimodal Monitoring of Radiotherapy Response in Squamous Cell CancerCompletedNCT02379039
- Safety Study of SEA-CD40 in Cancer PatientsTerminatedNCT02376699Phase 1
- Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric CancerStatus unknownNCT02375997Phase 3
- A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusStatus unknownNCT02353936Phase 2
- Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck CancerStatus unknownNCT02352792Not applicable
- Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck CancerCompletedNCT02350712Phase 1
- Ganetespib Window of Opportunity Study in Head and Neck CancersTerminatedNCT02334319Phase 1
- Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral CavityTerminatedNCT02331875Phase 1/2
- STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVEStatus unknownNCT02328391
- Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal CancerStatus unknownNCT02325986Phase 2
- Spanish Registry of Mohs SurgeryCompletedNCT02310503
- Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck CancerCompletedNCT02308072Phase 1
- CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure InvolvedStatus unknownNCT02303457Not applicable
- Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT02298595Phase 1/2